The effect of age on the expression of interleukin-2

Mechanisms of Ageing and Development

Volumn 89, Issue 3, 1996, Pages 125-154

  Pahlavani, Mohammad A ^a,b   Richardson, Arlan ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Aging; Immune system; Interleukin 2; Transcription; Transcription factors

Indexed keywords

INTERLEUKIN 2; TRANSCRIPTION FACTOR;

AGING; CELLULAR IMMUNITY; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA; RODENTIA;

EID: 0030605949     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/0047-6374(96)01725-3     Document Type: Review

References (188)

1. [1] K.A. Smith, Interleukm 2. Annu. Rev. Immunol., 2 (1984) 319-335.
2. [2] F.R. Balkwill, Cytokines: A Practical Approach, Oxford University Press, New York, 1991.
3. [3] T. Makinodan and M.M.B. Kay, Age influence on the immune system. Adv. Immunol., 29 (1980) 287-330.
4. [4] M.A. Pahlavani, Immunological aspects of aging. Drugs Today, 23 (1987) 611-624.
5. [5] M.L. Thoman and W.O. Weigle, The cellular and subcellular bases of immunosenescence. Adv. Immunol., 46 (1989) 221-261.
6. [6] D.M. Murasko and I.M. Goonewardene, T-cell function in aging: mechanisms of decline. Ann. Rev. Gerontol., 10 (1990) 71-96.
7. [7] R.A. Miller, Aging and immune function. Int. Rev. Cytol., 124 (1991) 187-215.
8. [8] R.A. Miller, Aging and immune function: cellular and biochemical analysis. Exp. Gerontol., 29 (1994) 21-35.
9. [9] K. Hirokawa, Autoimmunity and Aging. In J.M. Cruse and R.E.J. Lewis (eds.), Autoimmunity: Basic Concepts: Systemic and Selected Organ-Specific Diseases, Karger, Basel, 1985, pp. 251-288.
10. [10] K. Hirokawa, Aging and the immune system. In A.M. Kligman and Y. Takase (eds.), Cutaneous Aging, University of Tokyo Press, 1988, pp. 61-78.
11. [11] S. Antonaci, E. Jirilo, and L. Bonomo, Influence of senescence on B cell function. Med. Sci. Res., 16 (1988) 155-159.
12. [12] D. Nora, B. Bonavida, and R.L. Walford, The age-related response of mice of a long-lived strain to trinitrophenylated syngeneic mouse red blood cells. J. Immunol., 117 (1976) 2204-2208.
13. [13] Y.T. Kim, E.A. Goidl, and C. Samarut, Bone marrow function. I. Peripheral T cells are responsible for the increased autoantiidiotpe response of older mice. J. Exp. Med., 161 (1985) 1237-1241.
14. [14] D.H. Bovbjerg, Y.T. Kim, and R. Schwab, Cross-wiring of the immune response in old mice: Increased autoantibody response despite reduced antibody response to nominal antigen. Cell. Immunol., 135 (1991) 519-524.
15. [15] J. Radl, Age-related monoclonal gammapathies. Immunol. Today, 11 (1990) 234-236.
16. [16] M.J. Rowley, H. Buchanan, and I.R. Mackay, Reciprocal change with age in antibody to extrinsic and intrinsic antigens. Lancet 2 (1968) 24-26.
17. [17] Y. Shoenfeld and D. Isenberg, Ageing and autoimmunity. The Mosaic of Autoimmunity, Elsevier, New York, 1989.
18. [18] M.R. Szewczuk and R.J. Campbell, Loss of immune competence with age may be due to auto-anti-idiotypic antibody regulation. Nature, 286 (1980) 164-165.
19. [19] D. Segre, R.A. Miller, G.N. Abraham, Aging and the immune system. J. Gerontol., 44 (1989) B164-B168.
20. [20] K. Hayakawa, R.R. Hardy, and L.A. Herzenberg, Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur. J. Immunol., 16 (1986) 450-456.
21. [21] M.E. Weksler, Immune senescence and adrenal steroids: immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals. J. Clin. Pharmacol., 45 (1993) S21-S23.
22. [22] D.A. Morgan, F.W. Ruscetti and R.C. Gallo, Selective in vitro growth of T lymphocytes from normal bone marrows. Science, 93 (1976) 1007-1008.
23. [23] L.A. Aarden and T.K. Brunner, Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors. J. Immunol., 123 (1979) 2928-2939.
24. [24] M. Malkowsky and P.B. Medawar, Is immunological tolerance (non-responsiveness) a consequence of interleukin-2 deficit during the recognition of antigen? Immunol. Today, 5 (1984) 340-347.
25. [25] M. M. Dawson, Lymphokines and Interleukins, CRC Press, Boca Raton, FL, 1991, pp. 106-128.
26. [26] S.A. Rosenberg, P. Spiess and R. Lafreniere, A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science, 233 (1986) 1318-1321.
27. [27] C.S. Henney, K. Kurabayashi, D.E. Kern and S. Gillis, Interleukin-2 augments natural killer cell activity. Nature, 291 (1981) 335-338.
28. [28] S.A. Rosenberg, M.T. Lotze, L.M. Muul, A.E. Chang, F.P. Avis, S. Leitman, W.M. Linehan, C.N. Robertson, R.E. Lee, J.T. Rubin, C.A. Siepp, C.G. Simpson and D. White, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med., 316 (1987) 889-897.
29. [29] S. Taira, M. Matsui, K. Hayakawa, T. Yokoyama and H. Nariuchi, Interleukin-2 secretion by B cell lines and splenic B cells stimulated with calcium ionophore and phorbol ester. J. Immunol., 139 (1987) 2957-2964.
30. [30] T.R. Mosmann and R.L. Coffman, Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol., 7 (1989) 145-173.
31. [31] R.J. Robb, R.M. Kutny, and M. Panico, Amino acid sequence and post-translational modifications of human interleukin-2. Proc. Natl. Acad. Sci., 81 (1984) 6486-6491.
32. [32] R. Devos, G. Plaetinck, H. Cheroutre, G. Simons, W. Degrave, J. Tavernier, E. Remaut and W. Fiers, Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res., 11 (1983) 4307-4323.
33. [33] T. Taniguchi, H. Matsui, T. Fujita et al., Structure and expression of a cloned cDNA for human interleukin-2. Nature (London), 302 (1983) 305-307.
34. [34] S.J. Chen, N.J. Holbrook, K.F. Mitchell, C.A. Vallone, J.S. Greengard, G.R. Crabtree and Y. Lin, A viral long terminal repeat in the interleukin 2 gene of a cell line that constitutively produces interleukin 2. Proc. Natl. Acad. Sci. USA, 82 (1985) 7284-7288.
35. [35] D.P. Cerretti, K. McKereghan, A. Larsen, M.A. Cantrell, D. Anderson, S. Gillis, D. Cosman and P.E. Baker, Cloning, sequence, and expression of bovine interleukin 2. Proc. Natl. Acad. Sci. USA, 83 (1986) 3223-3227.
36. [36] R. Reeves, A.G. Spies, M.S. Nissen, C.D. Buck, A.D. Weinberg, P.J. Barr, N.S. Magnuson and J.A. Magnuson, Molecular cloning of a functional bovine interleukin 2 cDNA. Proc. Natl. Acad. Sci. USA, 83 (1986) 3228-3232.
37. [37] T. Yokota, N. Arai, F. Lee, D. Rennick, T. Mosmann and K.-I. Arai, Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc. Natl. Acad. Sci. USA, 82 (1985) 68-72.
38. [38] A.J. McKnight, D.W. Mason and A.N. Barclay, Sequence of rat interleukin 2 and anomalous binding of a mouse interleukin 2 cDNA probe to rat MHC class II-associated invariant chain mRNA. Immunogenetics, 30 (1989) 145-147.
39. [39] R.J. Robb and W.C. Greene, Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen. J. Exp. Med., 158 (1983) 1332-1337.
40. [40] B.J. Brandhuber, T. Boone, W.C. Kenney and D.B. McKay, Three-dimensional structure of interleukin-2. Science, 238 (1987) 1707-1709.
41. [41] M.L. Thoman and W.O. Weigle, Lymphokines and aging: Interleukin-2 production and activity in aged animals. J. Immunol., 127 (1981) 2101-2106.
42. [42] M.L. Thoman and W.O. Weigle, Cell-mediated immunity in aged mice: An underlying lesion in IL-2 synthesis. J. Immunol., 128 (1982) 2358-2361.
43. [43] M. Chang, T. Makinodan, W.J. Peterson and B.L. Strechler, Role of T cells and adherent cells in age-related decline in murine interleukin 2 production. J. Immunol., 129 (1982) 2426-2430.
44. [44] M.L. Thoman, Role of interleukin-2 in the age-related impairment of immune function. J. Am. Geriatr. Soc., 33 (1985) 781-787.
45. [45] S.R.A. Gottesman, R.L. Walford and G.J. Thorbecke, Proliferative and cytotoxic immune functions in aging mice. III. Exogenous interleukin-2 rich supernatant only partially restores alloreactivity in vitro. Mech. Ageing Dev., 31 (1985) 103-110.
46. [46] M. Iwashima, T. Nakayama, M. Kubo, Y. Asano and T. Tada, Alterations in the Proliferative Responses of T Cells from Aged and Chimeric Mice. Int. Archs Allergy appl. Immun., 83 (1987) 129-137.
47. [47] D.D. Li, Y.K. Chien, M.Z. Gu, A. Richardson and H.T. Cheung, The age-related decline in interleukin-3 expression in mice. Life Sci., 43 (1988) 1215-1222.
48. [48] M.L. Thoman and W.O. Weigle, Partial restoration of Con A-induced proliferation, IL-2 receptor expression, and IL-2 synthesis in aged murine lymphocytes by phorbol myristate acetate and ionomycin. Cell. Immunol., 114 (1988) 1-11.
49. [49] J.J. Proust, D.S. Kittur, M.A. Buchholz and A.A. Nordin, Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice. J. Immunol., 141 (1988) 4209-4216.
50. [50] M.-P. Chang, M. Utsuyama, K. Hirokawa and T. Makinodan, Decline in the production of interleukin-3 with age in mice. Cell. Immunol., 115 (1988) 1-12.
51. [51] D.N. Ernst, W.O. Weigle, D.N. McQuitty, A.L. Rothermel and M.V. Hobbs, stimulation of Murine T Cell Subsets with Anti-CD3 Antibody. J. Immunol., 142 (1989) 1413-1421.
52. [52] T.C. Fong and T. Makinodan, In Situ Hybridization Analysis of the Age-Associated Decline in IL-2 mRNA Expressing Murine T Cells. Cell. Immunol., 118 (1989) 199-207.
53. [53] M. Provinciali, M. Muzzioli and N. Fabris, Timing of appearance and disappearance of IFN and IL-2 induced natural immunity during ontogenetic development and aging. Exp. Gerontol., 24 (1989) 227-236.
54. [54] H. Yoshii, H. Kawakubo, T. Matsuoka, S. Suehiro, Y. Yanagihara, S. Negoro and S. Kishimoto, Restorative effect of neurotropin on maturation of bone marrow cells to IL-2-producing T-cells in aging BALB/c mice. Int. J. Immunopharmacol., 13 (1991) 859-864.
55. [55] C. Vissinga, A. Hertogh-Huijbregts, J. Rozing and L. Nagelkerken, Analysis of the age-related decline in alloreactivity of CD4+ and CD8+ T cells in CBA/RIJ mice. Mech. Ageing Dev., 51 (1990) 179-194.
56. [56] A. Hertogh-Huijbregts, C. Vissinga, J. Rozing and L. Nagelkerken, Impairment of CD3-dependent and CD3-independent activation pathways in CD4+ and in CD8+ T cells from old CBA/RIJ mice. Mech. Ageing Dev., 53 (1990) 141-155.
57. [57] K. Koyama, T. Hosokawa and A. Aoike, Aging effect on the immune functions of murine gut-associated lymphoid tissues. Dev. Comp. Immunol., 14 (1990) 465-473.
58. [58] R.A. Miller, Caloric restriction and immune function: developmental mechanisms. Aging Clin. Exp. Res., 3 (1991) 395-402.
59. [59] H. Kawanishi and K. Joseph, Effects of phorbol myristate and ionomycin on in vitro growth of aged Peyer's patch T and B cells. Mech. Ageing Dev., 65 (1992) 289-300.
60. [60] E. Cillari, S. Milano, M. Dieli, F. Arcoleo, R. Perego, F. Leoni, G. Gromo, A. Severn and F.Y. Liew, Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T-cell subsets. Immunology, 76 (1992) 362-366.
61. [61] M.V. Hobbs, W.O. Weigle, D.J. Noonan, B.E. Torbett, R.J. McEvilly, R.J. Koch, G.J. Cardenas and D.N. Ernst, Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol., 150 (1993) 3602-3614.
62. [62] A. Saini and Y. Sei, Age-related impairment of early and late events of signal transduction in mouse immune cells. Life Sci., 52 (1993) 1759-1765.
63. [63] R. Gorczynski, S. Dubiski, P.G. Munder, B, Cinader and O. Westphal. Age-related changes in interleukin production in BALB/cNNia and SJL/J mice and their modification after administration of foreign macromolecules. Immunol. Lett., 38 (1993) 243-251.
64. [64] D.A. Kirshmann and D.M. Murasko, Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell. Immunol., 139 (1992) 426-437.
65. [65] C. Vissinga, C.J.A.M. Dirven, F.A. Steinmeyer, R. Benner and W.J.A. Boersma, Deterioration of cellular immunity during aging. The relationship between age-dependent impairment of delayed-type hypersensitivity reactivity, interleukin-2 production capacity, and frequency of Thy-1 + , Lyt-2 - cells in C57BL/Ka and CBA/Rij mice. Cell. Immunol., 108 (1987) 323-334.
66. [66] M. H. Bocchieri, J.L. Sabol, and D.K. O'Neill, Age-related decline in cell-mediated immunity in the C58 leukemic mouse strain. Gerontol., 34 (1988) 221-230.
67. [67] R.A. Daynes and B.A. Araneo, Prevention and reversal of some age-associated changes in immunological responses by supplemental dehydroepiandrosterone sulfate therapy. Aging Immunol. Infect. Dis., 3 (1992) 135-142.
68. [68] T. Fong and T. Makinodan, Preferential enhancement by 2-mercaptoethanol of IL-2 responsiveness of T blast cells from old over young mice is associated with potentiated protein kinase C translocation. Immunol. Lett., 20 (1989) 149-154.
69. [69] D.N. Ernst, M.V. Hobbs, B.E. Torbett, A.L. Glasebrook, M.A. Rehse, K. Bottomly, K. Hayakawa, R.R. Hardy and W.O. Weigle, Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J. Immunol., 145 (1990) 1295-1302.
70. [70] M.C. Caroleo, D. Frasca, G. Nistico, and G. Doria, Melatonin as immunomodulator in immunodeficient mice. Immunoparmacology, 23 (1992) 81-89.
71. [71] E. Cheng and H. Kawanishi, Age differences in interleukin production by gut-associated lymphoid tissues. Gastroenterology, 90 (1986) 1371 (Abst.).
72. [72] J.T. Venkatraman, V.G. Attwood, A. Turturro, R.W. Hart and G. Fernandes, Maintenance of virgin T cells and immune functions by food restriction during aging in long-lived B6D2F1 female mice. Aging: Immunol. and Infect. Dis., 5 (1994) 13-26.
73. [73] R.A. Windruch, J. Togo, and W.H. Adler, Supplemental zinc restores antibody formation in cultures of aged spleen cells. Clin. Immunol. and Immunopathol., 49 (1988) 215-225.
74. [74] H. Yoshii. S. Tatsumi, T. Matsuoka. S. Suehiro, J. Konishi, Y. Yanagihara, S. Negoro and S. Kishimoto, Immunopharmacological actions of an extract isolated from inflamed skin of rabbit inoculated wtih vaccinia virus (Neurotropin)-II. Restorative effect on immune responses through the recovery of IL-2 production in aging mice. J. Immunopharmacol., 11 (1989) 543-550.
75. [75] S.C. Gilman, J.S. Rosenberg and J.D. Feldman, T lymphocytes of young and aged rats. II. Functional defects and the role of Interleukin-2. J. Immunol., 128 (1982) 644-650.
76. [76] J.S. Rosenberg, S.C. Gilman and J.D. Feldman. Effects of aging on cell cooperation and lymphocyte responsiveness to cytokines. J. Immunol., 130 (1983) 1754-1758.
77. [77] H.T. Cheung, J.S. Twu and A. Richardson, Mechanism of the age-related decline in lymphocyte proliferation: role of IL-2 production and protein synthesis. Exp. Gerontol., 18 (1983) 451-460.
78. [78] W.T. Wu, M.A. Pahlavani, H.T. Cheung and A, Richardson, The effect of aging on the expression of interleukin 2 messenger ribonucleic acid. Cell. Immunol., 100 (1986) 224-231.
79. [79] D.R. Davila and K.W. Kelley, Sex differences in lectin-induced interleukin-2 synthesis in aging rats. Mech. Ageing Dev., 44 (1988) 231-240.
80. [80] M.A. Pahlavani, H.T. Cheung, J.A. Chesky and A. Richardson, Influence of exercise on the immune function of rats of various ages. J. Appl. Physiol., 64 (1988) 1997-2001.
81. [81] G. Fernandes, A. Khare, S. Langanier, B.P. Yu, L. Sandberg and B. Friedrichs, Effect of food restriction and aging on immune cell fatty acid, functions and oncogene expression in SPF Fischer 344 rats. Fed. Proc., 46 (1987) 567.
82. [82] H. Iwai and G. Fernandes, Immunological functions in food-restricted rats: enhanced expression of high-affinity interleukin-2 receptors on splenic T cells. Immunol. Lett., 23 (1990) 125-132.
83. [83] N.J. Holbrook, R.K. Chopra, M.T. McCoy, J.E. Nagel, D.C. Powers, W.H. Adler and E.L. Schneider. Expression of interleukin 2 and the interleukin 2 receptor in aging rats. Cell. Immunol., 120 (1989) 1-9.
84. [84] M.A. Pahlavani, H.T. Cheung, N.S. Cai and A. Richardson, Influence of dietary restriction and aging and gene expression in the immune system of rats. In A.L. Goldstein (ed.), Biomedical advances in aging, Plenum, New York, 1990, pp. 259-270.
85. [85] J. Venkatraman and G. Fernandes, Modulation of age-related alterations in membrane composition and receptor-associated immune functions by food restriction in Fischer 344 rats. Mech. Ageing Dev., 63 (1992) 27-44.
86. [86] M.A. Pahlavani, M.D. Harris and A. Richardson, The age-related decline in the induction of IL-2 transcription is correlated to changes in the transcription factor NFAT. Cell. Immunol., 165 (1995) 84-91.
87. [87] K.W. Kelley, S. Brief, H. J. Westley, J. Novakofski, P. J. Bechtel, J. Simon, and E. B. Waker, CH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA, 83 (1988) 5663-5669.
88. [88] G. Fernandes, E. Flescher and J.T. Venkatraman, Modulation of cellular immunity, fatty acid composition, fluidity and calcium influex by food restriction in aging rats. Aging: Immunol. and Infect. Dis., 2 (1990) 117-125.
89. [89] I. Nasrullah and R.S. Mazzeo, Age-related immunosenescence in Fischer 344 rats: influence of exercise training. J. Appl. Physiol., 73 (1992) 1932-1939.
90. [90] I. Goonerwardene, and D.M. Murasko, Age associated changes in mitogen induced proliferation and cytokine production by lymphocytes of the long-lived Brown Norway rat. Mech. Ageing Dev., 71 (1993) 199-212.
91. [91] I.M. Goonewardene and D.M. Murasko, Age-associated changes in mitogen-induced lymphoproliferation and lymphokine production in the long-lived Brown-Norway rat: effect of caloric restriction. Mech. Ageing Dev., (1995) in press.
92. [92] A.G. Ronnerberg, K.L. Gross, W.J. Hartman, S.N., Meydani, and R.L. Prior, Dietary arginine supplementation does not enhance lymphocyte proliferation or interleukin-2 production in young and aged rats. J. Nutr., 121 (1991) 1270-1278.
93. [93] R.A. Franklin, S. Arkins. and K.W. Kelley, The proliferative response of rat T cells to calcium ionophores increases with age. Cell. Immunol., 130 (1990) 416-428.
94. [94] S. Gillis, R. Kozak, M. Durante and M.E. Weksler, Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J. Clin. Invest., 67 (1981) 937-942.
95. [95] B. Kennes, D. Brohee and P. Neve, Lymphocyte activation in human ageing. V. Acquisition of response to T cell growth factor and production of growth factors by mitogen-stimulated lymphocytes. Mech. Ageing Dev., 23 (1983) 103-113.
96. [96] H. Rabinowich, T. Goses, T. Reshef and A. Klajman. Interleukin-2 production and activity in aged humans. Mech. Ageing Dev., 32 (1985) 213-226.
97. [97] G.W. Canonical. G. Ciprandi, M. Caria, W. Dirienzo, A. Shums, B. Norton-koger, and H.H. Fudenberg, Defect of autologous mixed lymphocyte reaction and interleukin-2 in aged individuals. Mech. Ageing Dev., 32 (1985) 205-212.
98. [98] R.K. Chopra, J.E. Nagel, F.J. Chrest and W.H. Adler, Impaired phorbol ester and calcium ionophore induced proliferation of T cells from old humans. Clin. Exp. Immunol., 70 (1987) 456-462.
99. [99] S. Brill, T. Kukulansky, E. Tal, L. Abel, Y. Polgin, C. Dassa and A. Globerson, Individual changes in T lymphocyte parameters of old human subjects. Mech. Ageing Dev., 40 (1987) 71-79.
100. [100] H. Hara, S. Negoro, S. Miyata, O. Saiki, K. Yoshizaki, T. Tanaka, T. Igarashi and S. Kishimoto, Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions. Mech. Ageing Dev., 38 (1987) 245-258.
101. [101] P.L. Meroni, W. Barcellini, D. Frasca, C. Sguotti, M.O. Borghi, G. De Bartolo, G. Doria and C. Zanussi, In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Clin. Immunol. Immunopathol., 42 (1987) 151-159.
102. [102] H. Hara, T. Tanaka, S. Negoro, Y. Deguchi, S. Nishio, O. Saiki and S. Kishimoto, Age-related changes of expression of IL-2 receptor subunits and kinetics of IL-2 internalization in T cells after mitogenic stimulation. Mech. Ageing Dev., 45 (1988) 167-175.
103. [103] C.J. Froelich, J.S. Burkett, S. Guiffaut, R. Kingsland and D. Brauner, Phytohemagglutinin induced proliferation by aged lymphocytes: reduced expression of high affinity interleukin-2 receptors and interleukin-2 secretion. Life Sci., 43 (1988) 1583-1590.
104. [104] A. Amadori, P. Zanovello, E. Cozzi, V. Ciminale, F. Borghesan, U. Fagiolo and G. Crepaldi, Study of some early immunological parameters in aging humans. Gerontology, 34 (1988) 277-283.
105. [105] J.E. Nagel, R.K. Chopra, F.J. Chrest, M.T. McCoy, E.L. Schneider, N.J. Holbrook and W.H. Adler, Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J. Clin. Invest., 81 (1988) 1096-1102.
106. [106] R.K. Chopra, N.J. Holbrook, D.C. Powers, M.T. McCoy, W.H. Adler and J.E. Nagel, Interleukin 2, interleukin 2 receptor, and interferon-y synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin. Immunol. Immunopathol., 53 (1989) 297-308.
107. [107] I. Beckman, K. Dimopoulos, X. Xaioning, J. Bradley, P. Henschke and M. Ahern, T cell activation in the elderly: evidence for specific deficiencies in T cell/accessory cell interactions. Mech. Ageing Dev., 51 (1990) 265-276.
108. [108] D.M. Murasko, B.J. Nelson, D. Matour, I.M. Goonewardene and D. Kaye, Heterogeneity of changes in lymphoproliferative ability with increasing age. Exp. Gerontol., 26 (1991) 269-279.
109. [109] S.N. Meydani, S. Endres, M.M. Woods, B.R. Goldin, C. Soo, A. Morrill-Labrode, C.A. Dinarello and S.L. Gorbach, Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J. Nutr., 121 (1991) 547-555.
110. [110] G. Candore, G. Di Lorenzo, C. Caruso, M.A. Modica, A.T. Colucci, G. Mitogen responsive T cell precursors in human beings is completely restored by interleukin-2. Mech. Ageing Dev., 63 (1992) 297-307.
111. [111] G.E. De Greef, G.J. Van Staalduinen, H. Van Doorninck, M.J.D. Van Tol and W. Hijmans, Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T-cell proliferation in individuals who met the health criteria of the Senieur protocol. Mech. Ageing Dev., 66 (1992) 1-14.
112. [112] Y.-P. Huang, J.-P. Pechere, M. Michel, L. Gauthey, M. Loreto, J.A. Curran and J.-P. Michel, In vivo T cell activation, in vitro defective IL-2 secretion, a response to influenza vaccination in elderly women. J. Immunol., 145 (1992) 715-722.
113. [113] L. Song, Y.H. Kim, R.K. Chopra, J.J. Proust, J.E. Nagel, A.A. Nordin and W.H. Adler, Age-related effects in T cell activation and proliferation. Exp. Gerontol., 28 (1993) 313-321.
114. [114] J. Sindermann, A. Kruse, H.-J. Frercks, R.M. Schutz and H. Kirchner, Investigations of the lymphokine system in elderly individuals. Mech. Ageing Dev., 70 (1993) 149-159.
115. [115] J.F. Gauchat, A.L. deWeck and B.M. Stadler, Aging: Immunol. Infect. Dis., 1 (1988) 191-204.
116. [116] M.T. Hessen, D. Kaye and D.M. Murasko, Heterogenous effects of exogenous lymphokines on lymphoproliferation of elderly subjects. Mech. Ageing Dev., 55 (1991) 61-73.
117. [117] Q.C. Ryan and D.M. Murasko, Effect of age on mitogen induced lymphokine production: Alteration of IL-2 and Interferon-gamma gene expression in elderly humans. Mech. Ageing Dev. 1995 (submitted).
118. [118] S. Negoro, H. Hara. S. Miyata, O. Saiki, T. Tanaka, K. Yoshizaki, T. Igarashi and S. Kishimoto, Mechanismas of age-related decline in antigen-specific T cell proliferative response of IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified Tac positive T cells. Mech. Ageing Dev., 36 (1986) 223-241.
119. [119] W. Barcellini, P.L. Meroni, M.O. Borghi, D. Frasca, R. Perego, G. Doria, and C. Zanuss, In vivo immunopotentiating activity of thymopentin in aging humans: Modulation of IL-2 receptor expression. Clin. Immunol. and Immunopathol., 48 (1988) 140-149.
120. [120] G.W. Canonica, M. Caria, D. Venuti, G. Cipro, G. Ciprandi and M. Bagnasco, T cell activation through different membrane structures (T3/Ti, T11, T44) and frequency analysis of proliferating and interleukin-2 producer T lymphocyte precursors in aged individuals. Mech. Ageing Dev., 42 (1988) 27-35.
121. [121] X. Zu, I. Beckman, and J. Bradley, Age-related changes in the expression of IL-2 and high affinity IL-2 binding sites. Int. Arch. Allergy Immunol., 102 (1993) 224-231.
122. [122] T. Zhou, C. K. Edwards, and J.D. Mountz, Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J. Exp. Med., 182 (1995) 129-137.
123. [123] D. Wu, S.N. Meydani, J. Sastre, M. Hayek, and M. Meydani, In vitro glutathione supplementation enhances interleukin-2 production and mitogeneic response of peripheral blood mononuclear cells from young and old subjects. J. Nutr., 124 (1994) 655-663.
124. [124] S. Negoro, H. Hara, S. Miyata, O. Saiki, T. Tanaka, K. Yoshizaki, N. Hishimoto, and S. Kishimoto. Age-related changes of T cell subsets: predominant defect of the proliferative response in CD8 positive T cell subset in aged persons, Mech. Ageing Dev., 39 (1987) 263-279.
125. [125] L. Guidi, C. Bartoloni, D. Frasca, L. Antico, R. Pili, F. Cursi, E. Tempetsta, C. Rumi, E. Menini, P. Carbonin, G. Doria and G. Gambassi, Impairment of lymphocyte activities in depressed aged subjects. Mech. Ageing Dev., 60 (1991) 13-24.
126. [126] R.A. Miller, Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cells. J. Immunol., 132 (1984) 63-68.
127. [127] P. De-Paoli, P. Battistin and G.F. Santini, Age-related changes in human lymphocyte subset: Progressive reduction of the CD4, CD45R (suppressor inducer) population. Clin. Immunol. Immunopathol., 48 (1988) 290-296.
128. [128] H.M. Serra, J.F. Krowka, J.A. Ledbetter and L.M. Pilarski, Loss of CD45R (LP220) represents a post-thymic T cell differentiation event. J. Immunol., 140 (1988) 1435-1439.
129. [129] C. Walker, J.F. Gauchat, A.L. deWeck and B.M. Stadler, Analysis of leukocyte markers in elderly individuals. Aging: Immunol. Infect. Dis., 2 (1990) 31-36.
130. [130] M. Utsuyama, K. Hirokawa, C. Kurashima, M. Fukayama, T. Inamatsu, K. Suzuki, W. Hashimoto and K. Sato, Differential age-change in the numbers of CD4 + CD45RA + and CD4 + CD29 + T cell subsets in human peripheral blood. Mech. Ageing Dev., 63 (1992) 57-68.
131. [131] R.P. Warren, L.J. Yonk, R.A. Burger and V.K. Singh, Age-related changes in CD45R + andCDw29 helper T cells in human subjects. Aging: Immunol. Infect. Dis., 2 (1990) 91-94.
132. [132] R. Miller, Accumulation of hyporesponsive, calcium extruding memory T cells as key feature of age-dependent immune dysfunction. Clin. Immunol. Immunopathol., 58 (1991) 305-317.
133. [133] L. Nagelkerken, A. Hertogh-Huijbregts, R. Dobber and A. Draeger, Age-related changes in lymphokine production related to a decreased number of CD45RBhiCD4 + cells. Eur. J. Immunol., 21 (1991) 273-281.
134. [134] A. Lerner, T. Yamada and R.A. Miller, Pgp-1 + T lymphocytes accumulate with age in mice and respond poorly to concanavalin-A. Eur. J. Immunol., 19 (1989) 977-982.
135. [135] D.N. Ernst, W.O. Weigle, D.J. Noonan, D.N. McQuitty and M.V. Hobbs, The age-associated increase in IFN-y synthesis by mouse CD8 + T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J. Immunol., 151 (1993) 575-587.
136. [136] M.A. Pahlavani and A. Richardson, Age-related decrease in the naive (OX22 +) T cells in F344 rats. Mech. Ageing Dev., 74 (1994) 171-176.
137. [137] M.D. Sanders, M.W. Makgoba and S. Shaw. Human naive and memory T cells; reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today, 9 (1988) 195-297.
138. [138] S. Ehlers and K.A. Smith, Differentiation of T cell lymphockine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med., 173 (1992) 25-36.
139. [139] I. Papp, K.J. Wieder, T. Sablinski, P.J. O'Connell, E.L. Milford, T.B. Strom and J.W. Kupiec-Weglinski, Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J. Immunol., 148 (1992) 1308-1314.
140. [140] E.J. Masoro, I. Shimokawa and B.P. Yu, Retardation of the aging processes in rats by food restriction. Ann. NY Acad. Sci., 621 (1991) 337-352.
141. [141] E.J. Masoro, Use of rodents as models for the study of "normal aging": Conceptual and practical issues. Neurobiol. Aging, 12 (1991) 639-643.
142. [142] E.J. Masoro, Dietary Restriction. Exp. Gerontol., 30 (1995) 291-298.
143. [143] L.K.L. Jung, M.A. Palladino, S. Calvano, D.A. Mark, R.A. Good and G. Fernandes, Effect of calorie restriction on the production and responsiveness to interleukin 2 in (NZBxNZW)F1 mice. Clin. Immunol. Immunopathol., 25 (1982) 295-301.
144. [144] K. Hishinuma, T. Nishimura, A. Konno, Y. Hashimoto and S. Kimura, The effect of dietary restriction on mouse T cell functions. Immunol. Lett., 17 (1988) 351-356.
145. [145] G.L. Coleman. S.W. Barthold, G.W. Osbaldiston, S.J. Foster and A.M. Jonas, Pathological changes during aging in barrier-reared Fischer 344 male rats. J. Gerontol., 32 (1977) 258-278.
146. [146] A.A. Nordin and G.D. Collins, Limiting dilution analysis of alloreactive cytotoxic precursor cells in aging mice. J. Immunol., 131 (1983) 2215-2218.
147. [147] R.A. Miller, Immunodeficiency of aging: Restorative effects of phorbol ester combined with calcium ionophore. J. Immunol., 137 (1986) 805-808.
148. [148] M. Bruley-Rosset and B. Payelle, Deficient tumor-specific immunity in old mice: in vivo mediation by suppressor cells, and correction of the defect by interleukin 2 supplementation in vitro but not in vivo. Eur. J. Immunol., 17 (1987) 307-312.
149. [149] H. Kawanishi and J. Kiely, Impaired non-specific suppressor-inducer T-cell activity in aged murine Peyer's patches, which can be corrected largely by IL-2 in vitro. Immunology, 66 (1989) 61-68.
150. [150] S. Ajitsu, S. Mirabella and H. Kawanishi, In vivo immunologic intervention in age-related T cell defects in murine gut-associated lymphoid tissues by IL-2. Mech. Ageing Dev., 54 (1990) 163-183.
151. [151] S.-P. Ho, K.E. Kramer and W.B. Ershler. Effect of host age upon interleukin-2-mediated anti-tumor responses in a murine fibrosarcoma model. Cancer Immunol. Immunother., 31 (1990) 146-150.
152. [152] H. Kawanishi and S. Ajitsu, Correlation of antigen-specific T cell defects in aged murine gut-associated lymphoid tissues an immune intervention by combined adoptive transfer of an antigen-specific immunoregulatory CD4 T cell subset and interleukin-2 administration. Eur. J. Immunol., 21 (1991) 2907-2914.
153. [153] C. Vissinga, L. Nagelkerken, J. Zijlstra, A. Hertogh-Huijbregts, W. Boersms, and J. Rozing, A decreased functional capacity of CD4+ T cells underlies the impaired DTH reactivity in old mice. Mech. Ageing Dev., 53 (1990) 127-139.
154. [154] J. Kutza and D.M. Murasko, Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-à. Cell. Immunol., 155 (1994) 195-204.
155. [155] S. Antonaci, A. Polignano, C. Tortorella, A.R. Garofalo, E. Jirillo and L. Bonomo, Role of interleukin 2, interleukin 4 and interleukin 5 in the T helper cell-driven B cell polyclonal differentiation in the elderly. Cytobios, 70 (1992) 77-85.
156. [156] M. Provinciali, G.D. Stefano, M. Colombo, F.D. Croce, M.C. Gandolfi, L. Daghetta, M. Anichini, R.D. Bitta, and N. Fabris, Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjects. Mech. Ageing Dev., 77(1994) 75-82.
157. [157] M.L. Thoman and W.O. Weigle, Reconstitution of in vivo cell-mediated lympholysis responses in aged mice with interleukin-2. J. Immunol., 134 (1985) 946-952.
158. [158] M.L. Thoman, D.N. Ernst, M.V. Hobbs, and W.O. Weigle, T cell differentiation and functional maturation in aging mice. In S.S. Yang and H.R. Warner (eds.), The underlying Molecular, Cellular, and Immunological Factors in Cancer and Aging, Plenum Press, New York. 1993, pp. 93-106.
159. [159] M. Ellis, An introduction to transcription. In D. Carney and K. Sikora (eds.), Genes and Cancer, Wiley, Chichester, UK, 1990, pp. 107-125.
160. [160] P. Angel, E. A., Allegretto, S.T. Okino, K. Hattari, Boyle, T. Hunter, and M. Karin, Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature, 332 (1988) 166-168.
161. [161] D. Bohmann, T. J. Bos, A. Admon, T. Nishimura, P. K. Vogt, and R. Tjian, Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcriptional factor AP-1. Science, 288 (1987) 1386-1388.
162. [162] P.J. Mitchell, and R. Tjian, Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science, 245 (1989) 371-373.
163. [163] K.S. Ullman, J. P. Northrop, C. L. Verweij, and G. R. Crabtree, Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol., 8 (1990) 421-442.
164. [164] J.S. Riegel, B. Corthesy, W. M. Flanagan, and G. R. Crabtree, Regulation of the interleukin-2 gene. Chem Immunol., 51 (1992) 266-287.
165. [165] E. Serfling, R. Barthelmas, I. Pfeuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin, Ubiquitous and lymphocyte-specific fators are involved in the induction of the mouse interleukin-2 gene in T lymphocytes. EMBO J., 8 (1989) 465-472.
166. [166] T.M. Williams, D. Moolten, J. Burlein, J. Romano, R. Bhaeraman, A. Godlillot, M. Mellon, J.F. Rauscher, and J.A. Kant, Identification of a zinc finger protein that inhibits IL-2 gene expression. Science, 254 (1991) 1791-1794.
167. [167] W.M. Flanagan, B. Corthesy, R. J. Bram, and G. R. Crabtree, Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature, 352 (1991) 803-805.
168. [168] C.L. Verweij, C. Guidos, and G.R. Crabtree, Cell type specificity and activation requirements for NFAT1 (nuclear factor of activated T cells) transcriptional activity determined by a new method using transgenic mice to assay transcriptional activity of an individual nuclear factor. J. Biol. Chem., 265 (1990): 15788-15795.
169. [169] C. Randak, T. Brabletz, M. Hergenrother, I. Sobotta. and E. Serfling, Cyclosporin A suppresses the expression of the interleulin-2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J., 9 (1990) 2529-2536.
170. [170] N.R. Yaseen, A. L. Maizel, F. Wang, and S. Sharma, Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J. Biol. Chem., 268 (1993) 14285-14289.
171. [171] J.P. Northrop, K. S. Ullman, and G.R. Crabtree. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NFAT) complex. J. Biol. Chem., 268 (1993) 2917-2921.
172. [172] J. Jain, V. E. Valge-Archer, and A. Rao. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol., 148 (1992) 1240-1245.
173. [173] E. Castigli, T. A. Chatila, and S.R. Geha, A protein of the AP-1 family is a component of nuclear factor of activated T cells. J. Immunol., 150 (1993) 3284-3288.
174. [174] C.B. Thompson, C. Wang, I. Ho, P. R. Bohjanen, B. Petryniak, C. H. June. S. Miesfeldt, L. Zhang, G. J. Nabel, B. Karpinski, and J.M. Leiden, cis-Acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol. Cell. Biol., 12 (1992) 1043-1047.
175. [175] A. Rao. NFATp a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J. Leukocyte Biol., 57 (1995) 536-542.
176. [176] J.P. Northrop, S.N. Ho. L. Chen, D.J. Thomas, L.A. Timmerman, G.P. Nolan, A. Admon, and G.R. Crabtree, NFAT components define a family of transcription factors targeted in T cell activation. Nature, 369 (1994) 497-502.
177. [177] X. Li, S. N. Ho, J. Luna, J. Giacalone. D.J. Thomas. L.A. Timmerman. G.R. Crabtree, and U. Francke, Cloning and chromosomal localization of the human and murine genes for the T cell transcription factors NFATc and NFATp. Cytogenet. Cell. Genet., 68 (1995) 185-191.
178. [178] L. Song. J. M. Stephens, S. Kittur, G. D. Collins. J. E. Nagel, P. H. Pekala. and W.H. Adler, Expression of c-fos, c-jun, and jun B in peripheral blood lymphocytes from young and elderly adults. Mech. Ageing Dev., 65 (1992) 149-155.
179. [179] E. Sikora, B. Kaminska, E. Radziszewska, and L. Kaczmarek, Loss of transcription factor AP-1 DNA binding activity during lymphocyte aging in vivo. FEBS Lett., 312 (1992) 179-184.
180. [180] M.A. Pahlavani, M.D. Harris and A. Richardson, Effect of age on T cell-specific and non-specific transcription factors in lymphocytes from F344 rats. American Aging Association, 25th Annual Meeting, 1995 (Abst. #26).
181. [181] R.A. Miller, B. Jacobson, G. Weil, and E.R. Simons, Diminished calcium influx in lectin-stimulated T cells from old mice. J. Cell. Physiol., 132 (1987) 337-341.
182. [182] J.J. Proust, C.R. Filburn, S.A. Harrison, M.A. Buchholz, and A.A. Nordin, Age-related defect in signal transduction during lectin activation of murine T lymphocytes. J. Immunol. 1987, 139 (1987) 1472-1477.
183. [183] D.A. Fruman, C. B. Klee, B. E. Bierer, and S. J. Burakoff, Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA, 89 (1992) 3686-3691.
184. [184] R.L. Kincaid, H. Takayama, M. L. Billingsley, and M. V. Sitkovsky, Differential expression of calmodulin-binding proteins in B, T lymphocytes and thymocytes. Nature (London), 330 (1987) 176-179.
185. [185] R.L. Kincaid and S.J. O'Keefe, Calcineurin and immunosuppression: A calmodulin-dependent protein phosphatase acts as the "gatekeeper" to interleukin-2 gene transcription. Adv. Proteins Phosphates, 7 (1993) 543-552.
186. [186] J. Liu, M.W. Albers, T.J. Wandless, S. Luan, D.G. Alberg, P.J. Belshaw, P. Cohen, C. Mackintosh, C.B. Klee, and S.L. Schreiber, Inhibition of T cell signalling by immunophilin-lingand complexes correlates with loss of calcineurin phosphatase activity. Biochem., 31 (1992) 3896-3899.
187. [187] N.A. Clipstone and G.R. Crabtree, Identification of calcineurin as a key signalling enzyme in T lymphocyte activation. Nature, 357 (1992) 695-697.
188. [188] P.G. McCaffrey, B.A. Perrino, T.R. Soderling, and A. Rao, NFAT-p, a T lymphocyte DNA binding protein that is a target for calcineurin and immunosuppressive drugs, J. Biol. Chem., 268 (1993) 3747-3752.